Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imipramine for Esophageal Hypersensitivity and Functional Heartburn
NCT01753128Phase 3Completed
- Sponsor
- Mahidol University
- Start
- Dec 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of imipramine in Functional heartburn (FH), esophageal hypersensitivity, sponsored by Mahidol University. Started Dec 2012; status: completed.
02
Drugs
imipramine
03
Conditions
Functional heartburn (FH)esophageal hypersensitivity
Beyond the preview
Go deeper on NCT01753128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01753128.